| $385M | ||
| $350M | ||
| $215M | ||
| $82M | ||
| $76M | ||
| $62M |
Buys | $7,028 | 1 | 50 |
Sells | $18,804 | 1 | 50 |
| Rubinstein Samuel | director | 1 | $7,028 | 1 | $18,804 | $-11,776 |
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC and Pharos excimer lasers, VTRAC lamp systems, and TheraClear treatment systems that are used for the treatment of psoriasis, vitiligo, acne, and other skin conditions. The company distributes its products internationally through distributors, and domestically directly to physicians. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.
Over the last 12 months, insiders at STRATA Skin Sciences, Inc. have bought $7,028 and sold $18,804 worth of STRATA Skin Sciences, Inc. stock.
On average, over the past 5 years, insiders at STRATA Skin Sciences, Inc. have bought $564,267 and sold $9,562 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Rubinstein Samuel (director) — $7,028.
The last purchase of 5,000 shares for transaction amount of $7,028 was made by Rubinstein Samuel (director) on 2025‑11‑18.
| 2025-11-18 | Rubinstein Samuel | director | 5,000 0.1198% | $1.41 | $7,028 | -7.97% | ||
| 2025-11-17 | Sale | Rubinstein Samuel | director | 14,094 0.303% | $1.33 | $18,804 | -13.01% | |
| 2024-07-15 | Geiger Uri | 230,573 6.5974% | $3.14 | $723,999 | -9.87% | |||
| 2024-07-15 | Accelmed Partners, L.P. | 10 percent owner | 230,573 6.5974% | $3.14 | $723,999 | -9.87% | ||
| 2024-07-15 | Rafaeli Dolev | Chief Executive Officer | 19,100 0.5465% | $3.14 | $59,974 | -9.87% | ||
| 2023-12-01 | Gov Shmuel | COO | 20,000 0.0586% | $0.45 | $8,956 | -15.72% | ||
| 2023-11-16 | Sale | Rubinstein Samuel | director | 1,000 0.0021% | $0.32 | $320 | -15.45% | |
| 2023-08-16 | 22NW, LP | 10 percent owner | 1.85M 5.0569% | $0.55 | $1.02M | -13.28% | ||
| 2023-08-10 | Moccia Robert Joseph | Chief Executive Officer | 42,000 0.1268% | $0.67 | $28,308 | -20.31% | ||
| 2023-08-10 | Lesovitz Christopher | Chief Financial Officer | 15,151 0.0455% | $0.67 | $10,153 | -20.31% | ||
| 2022-06-15 | Rubinstein Samuel | 1,050 0.0031% | $1.04 | $1,092 | -2.97% | |||
| 2022-05-12 | Lesovitz Christopher | Chief Financial Officer | 23,131 0.0691% | $1.12 | $25,907 | -7.82% | ||
| 2022-03-25 | Humphries William D. | 16,950 0.0523% | $1.73 | $29,385 | -38.33% | |||
| 2022-03-24 | Moccia Robert Joseph | Chief Executive Officer | 33,300 0.0962% | $1.57 | $52,398 | -36.34% | ||
| 2022-03-24 | Humphries William D. | 14,783 0.043% | $1.58 | $23,387 | -36.34% | |||
| 2021-09-08 | SHAMIR NACHUM | director | 44,808 0.1677% | $1.47 | $65,951 | -5.96% | ||
| 2021-09-07 | SHAMIR NACHUM | director | 26,612 0.0995% | $1.42 | $37,726 | -2.41% | ||
| 2019-11-21 | Via LuAnn | director | 5,000 0.0158% | $2.50 | $12,500 | -44.13% | ||
| 2018-06-14 | HILL MATTHEW C | CFO | 10,000 0.0431% | $1.96 | $19,618 | +42.05% | ||
| 2018-06-14 | Via LuAnn | director | 5,000 0.0214% | $1.95 | $9,750 | +42.05% |
| Rubinstein Samuel | director | 8766 0.2062% | $2,016.18 | 2 | 2 | <0.0001% |
| 22NW, LP | 10 percent owner | 5369954 126.3447% | $1.24M | 1 | 0 | <0.0001% |
| BONANZA CAPITAL LTD | 10 percent owner | 1524787 35.8753% | $350,701.01 | 1 | 11 | |
| Geiger Uri | 1441835 33.9236% | $331,622.05 | 1 | 0 | <0.0001% | |
| Accelmed Partners, L.P. | 10 percent owner | 1441835 33.9236% | $331,622.05 | 1 | 0 | <0.0001% |
| Broadfin Healthcare Master Fund Ltd | 10 percent owner | 1008297 23.7233% | $231,908.31 | 0 | 2 | |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 10 percent owner | 761726 17.922% | $175,196.98 | 0 | 12 | |
| Humphries William D. | 484440 11.3979% | $111,421.20 | 2 | 0 | <0.0001% | |
| Lufkin Dan W | 467115 10.9903% | $107,436.45 | 15 | 0 | ||
| Moccia Robert Joseph | Chief Executive Officer | 235300 5.5362% | $54,119.00 | 2 | 0 | <0.0001% |
| Gulfo Joseph V | Chairman, CEO & President | 208311 4.9012% | $47,911.53 | 14 | 0 | |
| SHAMIR NACHUM | director | 207792 4.8889% | $47,792.16 | 2 | 0 | <0.0001% |
| Rafaeli Dolev | Chief Executive Officer | 143156 3.3682% | $32,925.88 | 1 | 0 | <0.0001% |
| Coradini Robert | Chairman | 139024 3.271% | $31,975.52 | 5 | 0 | |
| Castleman Breaux | director | 107238 2.5231% | $24,664.74 | 7 | 0 | |
| DIMUN ANTHONY J | director | 101013 2.3766% | $23,232.99 | 2 | 0 | |
| Bronner William R | Vice-President, Legal Counsel | 75885 1.7854% | $17,453.55 | 1 | 0 | |
| Crane Rosemary A | CEO and President | 67570 1.5898% | $15,541.10 | 1 | 0 | |
| Chryssis George C | director | 41000 0.9647% | $9,430.00 | 11 | 0 | |
| Cleary Martin D | director | 40443 0.9515% | $9,301.89 | 10 | 0 | |
| Lesovitz Christopher | Chief Financial Officer | 38282 0.9007% | $8,804.86 | 2 | 0 | <0.0001% |
| Via LuAnn | director | 35570 0.8369% | $8,181.10 | 5 | 0 | +10.66% |
| Swintek Kathryn B | director | 33513 0.7885% | $7,707.99 | 3 | 0 | |
| STONE DAVID K | director | 23514 0.5532% | $5,408.22 | 2 | 0 | |
| Wagner Gerald D | Acting Chief Operating Officer | 20700 0.487% | $4,761.00 | 3 | 0 | |
| MCCANEY FRANK J | President & CEO | 20000 0.4706% | $4,600.00 | 1 | 0 | <0.0001% |
| NAVARRO SAMUEL E | director | 20000 0.4706% | $4,600.00 | 1 | 0 | +37.81% |
| Gov Shmuel | COO | 20000 0.4706% | $4,600.00 | 1 | 0 | <0.0001% |
| Egger Anne M | director | 16350 0.3847% | $3,760.50 | 5 | 0 | |
| ODONNELL JEFFREY F | director | 13513 0.3179% | $3,107.99 | 1 | 0 | |
| Cook Robert W. | Chief Financial Officer | 10000 0.2353% | $2,300.00 | 1 | 0 | +0.83% |
| HILL MATTHEW C | CFO | 10000 0.2353% | $2,300.00 | 1 | 0 | +42.05% |
| Goddard John Geoffrey | director | 10000 0.2353% | $2,300.00 | 1 | 0 | |
| Cheng-Avery Tina | V.P. of Commercialization | 8000 0.1882% | $1,840.00 | 1 | 0 | |
| MEADS MINDY C | director | 5070 0.1193% | $1,166.10 | 1 | 0 | |
| Steinhart Richard I | Chief Financial Officer | 4000 0.0941% | $920.00 | 2 | 0 | |
| COYNE JAMES L | director | 3000 0.0706% | $690.00 | 1 | 0 | +63.91% |
| Increased Positions | 5 | +22.73% | 34,111 | +2.96% |
| Decreased Positions | 8 | -36.36% | 96,311 | -8.36% |
| New Positions | 2 | New | 30,198 | New |
| Sold Out Positions | 5 | Sold Out | 51,371 | Sold Out |
| Total Postitions | 19 | -13.64% | 1M | -5.4% |
| 22Nw, Lp | $682.00 | 8.95% | 536,995 | 0 | 0% | 2025-09-30 |
| Nantahala Capital Management, Llc | $513.00 | 6.73% | 403,917 | 0 | 0% | 2025-09-30 |
| Renaissance Technologies Llc | $129.00 | 1.69% | 101,530 | +3,500 | +3.57% | 2025-09-30 |
| Vanguard Group Inc | $30.00 | 0.39% | 23,545 | -61,087 | -72.18% | 2025-09-30 |
| Azzad Asset Management Inc /Adv | $28.00 | 0.36% | 21,800 | +9,800 | +81.67% | 2025-09-30 |
| Geode Capital Management, Llc | $23.00 | 0.3% | 18,137 | -56 | -0.31% | 2025-09-30 |
| Mgo One Seven Llc | $22.00 | 0.29% | 17,142 | 0 | 0% | 2025-09-30 |
| Susquehanna International Group, Llp | $16.00 | 0.21% | 12,426 | +12,426 | New | 2025-09-30 |
| Creative Planning | $13.00 | 0.17% | 10,016 | 0 | 0% | 2025-09-30 |
| Blackrock, Inc. | $6.00 | 0.07% | 4,465 | 0 | 0% | 2025-09-30 |